KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Current Deferred Revenue (2016 - 2025)

National Health Investors (NHI) has disclosed Current Deferred Revenue for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 16.81% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2025, up 16.81%, and an annual FY2025 reading of $5.0 million, up 16.81% over the prior year.
  • Current Deferred Revenue was $5.0 million for Q4 2025 at National Health Investors, up from $4.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $11.0 million in Q1 2021 and bottomed at $4.0 million in Q3 2025.
  • Average Current Deferred Revenue over 5 years is $5.5 million, with a median of $5.1 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue crashed 60.95% in 2022, then rose 23.4% in 2023.
  • Year by year, Current Deferred Revenue stood at $5.7 million in 2021, then fell by 11.76% to $5.1 million in 2022, then increased by 18.94% to $6.0 million in 2023, then decreased by 28.82% to $4.3 million in 2024, then rose by 16.81% to $5.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for NHI at $5.0 million in Q4 2025, $4.0 million in Q3 2025, and $4.1 million in Q2 2025.